SP1 and malignant colon neoplasm: miR-22 expression inhibits cell migration and invasion via targeting transcription factor Sp1 [35], while it suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 (TIAM1) [36].